Viewing Study NCT03177460


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-02-09 @ 12:44 PM
Study NCT ID: NCT03177460
Status: COMPLETED
Last Update Posted: 2024-05-03
First Post: 2017-06-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Adenocarcinoma View
None Stage III Prostate Cancer AJCC v8 View
None Stage IIIA Prostate Cancer AJCC v8 View
None Stage IIIB Prostate Cancer AJCC v8 View
None Stage IIIC Prostate Cancer AJCC v8 View
None Testosterone Greater Than 150 ng/dL View
Keywords: